{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:18:53Z","timestamp":1790399933987,"version":"4.1.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2011,10,11]]},"DOI":"10.1212\/wnl.0b013e318232ac1a","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T06:14:47Z","timestamp":1316067287000},"page":"1487-1493","source":"Crossref","is-referenced-by-count":126,"title":["Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease"],"prefix":"10.1212","volume":"77","author":[{"given":"Jason","family":"Karlawish","sequence":"first","affiliation":[{"name":"From the Center for Neuroscience and Society, Alzheimer's Disease Center, Center for Bioethics, Departments of Medicine and Medical Ethics, University of Pennsylvania, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.179"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.2008"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70223-4"},{"key":"e_1_3_4_7_2","unstructured":"Alzheimer Disease International. \nWorld Alzheimer Report 2010: The Global Economic Impact of Dementia. \nLondon UK: \nAlzheimer Disease International; \n2010."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2010.01.009"},{"key":"e_1_3_4_9_2","unstructured":"S. 3036: National Alzheimer's Project Act of 2011: 111th Congress: Second Session (2011)."},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00010"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1624"},{"key":"e_1_3_4_12_2","unstructured":"National Institutes of Health National Heart Lung and Blood Institute. \nNational Cholesterol Education Program: Program Description. \nAvailable at: http:\/\/www.nhlbi.nih.gov\/about\/ncep\/ncep_pd.htm. \nAccessed January 26 2011."},{"key":"e_1_3_4_13_2","unstructured":"National Cholesterol Education Program (NCEP). \nThird Report of the Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Risk Assessment Tool for Estimating 10-year Risk of Developing Hard CHD (Myocardial Infarction and Coronary Death). \nAvailable at: http:\/\/hp2010.nhlbihin.net\/atpiii\/calculator.asp?usertype=prof. \nAccessed June 8 2010."},{"key":"e_1_3_4_14_2","unstructured":"Metlife Foundation. \nMetLife Foundation Alzheimer's Survey: What America Thinks. \nNew York: \nMetlife Foundation; 2006."},{"key":"e_1_3_4_15_2","article-title":"My genome, my self","author":"Pinker S","year":"2009","unstructured":"Pinker S . My genome, my self. New York Times. January 11, 2009: Sect. MM24.","journal-title":"New York Times"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70246-5"},{"key":"e_1_3_4_17_2","unstructured":"Venter JC\n. \nA Life Decoded: My Genome: My Life. \nNew York NY: \nViking; 2007."},{"key":"e_1_3_4_18_2","article-title":"Tests detect Alzheimer's risks, but should patients be told?","author":"Kolata G","year":"2010","unstructured":"Kolata G . Tests detect Alzheimer's risks, but should patients be told? New York Times. December 18, 2010: Sect. A1.","journal-title":"New York Times"},{"key":"e_1_3_4_19_2","article-title":"FDA sees promise in Alzheimer's imaging drug","author":"Kolata G","year":"2011","unstructured":"Kolata G . FDA sees promise in Alzheimer's imaging drug. New York Times. January 21, 2011: Sect. A1.","journal-title":"New York Times"},{"key":"e_1_3_4_20_2","unstructured":"23andMe Inc. \nAlzheimer's Disease: Genetic Testing. \nAvailable at: https:\/\/www.23andme.com\/health\/alzheimers\/. \nAccessed April 19 2011."},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809578"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2008.05.1358"},{"key":"e_1_3_4_23_2","first-page":"628","article-title":"A condensed genetic counseling approach for Alzheimer's disease susceptibility testing: what is the psychological impact?","volume":"18","author":"Szymaniak JM","year":"2009","unstructured":"Szymaniak JM, Christensen KD, Uhlmann WR, Green RC, Roberts JS . A condensed genetic counseling approach for Alzheimer's disease susceptibility testing: what is the psychological impact? J Genet Couns 2009; 18: 628. Abstract.","journal-title":"J Genet Couns"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.5-4-302"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460240051027"},{"key":"e_1_3_4_26_2","first-page":"193","volume-title":"Medicating Modern America: Prescription Drugs in History","author":"Greene JA","unstructured":"Greene JA . The Abnormal and the pathological: cholesterols, statins, and the threshold of disease. In: , Tone A, Siegel Watkins E , eds. Medicating Modern America: Prescription Drugs in History. New York: New York University Press; 2007:193\u2013228."},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.106.25.3143"},{"key":"e_1_3_4_29_2","unstructured":"Goozner M\n. \nPetition to the National Institutes of Health seeking an independent review panel to re-evaluate the National Cholesterol Education Program Guidelines. \nAvailable at: http:\/\/www.cspinet.org\/new\/pdf\/finalnihltr.pdf. \nAccessed March 2 2010."},{"key":"e_1_3_4_30_2","unstructured":"Alving B\n. \nPetition to the National Institutes of Health seeking an independent review panel to re-evaluate the National Cholesterol Education Program Guidelines: reply. \nAvailable at: http:\/\/www.nhlbi.nih.gov\/guidelines\/cholesterol\/response.htm. \nAccessed March 2 2010."},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2010.11.007"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69420-8"},{"key":"e_1_3_4_33_2","article-title":"Splits form over how to address bone loss","author":"Murphy K","year":"2009","unstructured":"Murphy K . Splits form over how to address bone loss. New York Times. September 8, 2009: Sect. D5.","journal-title":"New York Times"},{"key":"e_1_3_4_34_2","unstructured":"National Osteoporosis Foundation. \nClinician's Guide to Prevention and Treatment of Osteoporosis. \nWashington DC: \nNational Osteoporosis Foundation; \n2008."},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2008.04.003"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.081203"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69421-X"},{"key":"e_1_3_4_38_2","unstructured":"Rosenthal E\n. \nDrug can prevent diabetes in many at high risk study suggests. New York Times . \nAvailable at: http:\/\/www.nytimes.com\/2006\/09\/17\/world\/17diabetes.html. \nAccessed April 19 2011."},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-11-201006010-00254"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040119"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.187"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.164"},{"key":"e_1_3_4_43_2","unstructured":"Financial Industry Regulatory Authority. \nSenior Investor Suitability Considerations (EL-ELC134). \nAvailable at: http:\/\/www.finra.org\/web\/groups\/industry\/@ip\/@edu\/documents\/education\/p121536.pdf. \nAccessed August 27 2011."},{"key":"e_1_3_4_44_2","unstructured":"National Conference of Commissioners on Uniform State Laws. Uniform Power of Attorney Act . \nAvailable at: http:\/\/www.law.upenn.edu\/bll\/archives\/ulc\/dpoaa\/2008_final.htm. \nAccessed April 19 2011."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e318232ac1a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:20:16Z","timestamp":1711538416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e318232ac1a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":43,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2011,10,11]]}},"alternative-id":["10.1212\/WNL.0b013e318232ac1a"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e318232ac1a","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]}}}